Article
Physiogenomic analysis of CYP450 drug metabolism correlates dyslipidemia with pharmacogenetic functional status in psychiatric patients.
Biomarkers in medicine - 1 Aug 2011
Ruaño Gualberto, Villagra David, Szarek Bonnie, Windemuth Andreas, Kocherla Mohan, Gorowski Krystyna, Berrezueta Christopher, Schwartz Harold I, Goethe John
Abstract excerpt
AIMS: To investigate associations between novel human cytochrome P450 (CYP450) combinatory (multigene) and substrate-specific drug metabolism indices, and elements of metabolic syndrome, such as low density lipoprotein cholesterol (LDLc), high density lipoprotein cholesterol (HDLc), triglycerides and BMI, using physiogenomic analysis. METHODS: CYP2C9, CYP2C19 and CYP2D6 genotypes and clinical data were obtained...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
